The Leadership Team at Carisma Therapeutics drives the strategic vision and operational framework for pioneering CAR macrophage immunotherapy. Comprising key executives with diverse expertise in research, finance, and business development, the team collaborates to steer innovation, manage resources, and foster partnerships essential for advancing therapies aimed at treating solid tumors. Their collective leadership ensures alignment with the company’s mission while navigating the complexities of the biotech landscape.
View all